| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JN/134.1.5 |
| P698 | PubMed publication ID | 14704285 |
| P2093 | author name string | Michael F McEntee | |
| Carol C Ziegler | |||
| Jay Whelan | |||
| Leah Rainwater | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5-10 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Journal of Nutrition | Q3186931 |
| P1476 | title | Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/+) mice. | |
| P478 | volume | 134 |
| Q36695705 | Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene |
| Q36786996 | Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice |
| Q36403593 | Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrol |
| Q39722490 | Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol |
| Q51028538 | Fruit peel polyphenols demonstrate substantial anti-tumour effects in the model of breast cancer. |
| Q39511232 | In vitro and in vivo evaluation of the anticarcinogenic and cancer chemopreventive potential of a flavonoid-rich fraction from a traditional Indian herb Selaginella bryopteris |
| Q36844294 | Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention |
| Q33854808 | Mouse models for unraveling the importance of diet in colon cancer prevention |
| Q35155749 | Phytochemicals in cancer prevention and therapy: truth or dare? |
| Q54968761 | Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action. |
| Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
| Q36026600 | Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography |
| Q34418424 | Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer |
| Q33578943 | Resveratrol and cancer: focus on in vivo evidence |
| Q24618313 | Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence |
| Q34571083 | Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth |
| Q24675163 | Resveratrol: a review of preclinical studies for human cancer prevention |
| Q37826817 | The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges |
| Q35757899 | The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression. |
| Q38211073 | The role of inflammation in colon cancer |
| Q38938887 | The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models |
| Q21089966 | What is new for an old molecule? Systematic review and recommendations on the use of resveratrol |
Search more.